The Longevity Fund

Some of the companies we have backed:

ALX ONCOLOGY - Immuno-oncology drugs (IPO 2020) LOYAL - Dog lifespan extension

DECIBEL THERAPEUTICS - Therapeutics for age-related hearing loss (IPO 2021) EPIRIUM BIO - Mitochondrial biogenesis

FAUNA BIO - Drug discovery informed by hibernating mammals

GORDIAN BIOTECHNOLOGY - Multi-modal gene therapy for aging

METACRINE - Farnesoid drug development (IPO 2020) NAVITOR PHARMACEUTICALS - mTOR modifiers

PRECISION BIOSCIENCES - Gene editing (IPO 2019) SPRING DISCOVERY - ML aging drug discovery

SYSTEM1 BIOSCIENCES - Brain-organoid drug discovery

UNITY BIOTECHNOLOGY - Senolytics to increase healthspan (IPO 2018) We invest in Seed and Series A companies developing drugs for aging and age-related diseases We can lead and follow rounds FAQ here

Finding and supporting the next generation of biotech founders

WHO WE ARE // LAURA DEMING (GENERAL PARTNER & FOUNDER) + CELINE HALIOUA (VENTURE PARTNER)

CONTACT // INFO@LONGEVITY.VC —> STRAIGHT TO GP INBOX